GlassScriptPhysician profile
Marc M Sedwitz
NPI 1275613093
$4,106.64
in general payments reported to CMS, 2019-2025
20 companies · $1,966 in 2025
The $1,966 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $541 · 2020: $331 · 2021: $195 · 2022: $638 · 2023: $284 · 2024: $151 · 2025: $1,966.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,329 · Travel and Lodging: $1,072.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,329.30 |
| Travel and Lodging | $1,071.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,720.09 | 2025 | Indigo System, Penumbra System |
| Medtronic, INC. | $814.51 | 2022-2024 | Endurant Iis, Spiderfx |
| Silk Road Medical, INC. | $545.54 | 2019-2021 | |
| Medtronic Vascular, INC. | $309.10 | 2019-2020 | |
| Cook Medical LLC | $308.50 | 2019-2025 | Cook, Zilver Ptx, Zenith Spiral-Z |
| Bolton Medical INC | $57.03 | 2025 | Treo Abdominal Stent-Graft System |
| W. L. Gore & Associates, INC. | $47.75 | 2024 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Teleflex LLC | $43.87 | 2023 | Quikclot |
| Aroa Biosurgery Incorporated | $37.64 | 2022 | |
| Pfizer INC. | $35.22 | 2024 | |
| Ucb, INC. | $28.19 | 2024 | Briviact |
| Lemaitre Vascular, INC. | $26.02 | 2025 | Artegraft Vascular Graft |
| Biocompatibles, INC. | $22.62 | 2019 | |
| Merck Sharp & Dohme LLC | $19.36 | 2019 | |
| Cordis US Corp. | $18.29 | 2023 | Mynx Control |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $16.73 | 2022 | |
| Kls-Martin L.P. | $16.43 | 2020 | |
| Atricure, INC. | $15.10 | 2021 | |
| Tactile Systems Technology INC | $12.57 | 2020 | |
| Abbvie INC. | $12.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Sedwitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.